-
Clinical Year in Review Series Begins with Insights on Asthma, Interventional Pulmonary, Pulmonary Function Tests, and Sleep
on
Read more: Clinical Year in Review Series Begins with Insights on Asthma, Interventional Pulmonary, Pulmonary Function Tests, and SleepThe first session of the Clinical Year in Review series began with an exploration of evolving concepts and practice-changing studies in asthma, interventional pulmonary medicine, pulmonary function tests, and sleep medicine on Sunday, May 18, at the ATS 2025 International Conference.
-
Second Clinical Year in Review Session Explores Practice-Changing Findings and Emerging Concepts in General Critical Care, Sepsis, and More
on
Read more: Second Clinical Year in Review Session Explores Practice-Changing Findings and Emerging Concepts in General Critical Care, Sepsis, and MoreThe Clinical Year in Review series continued at ATS 2025 San Francisco with an examination of studies with clinical practice implications, and a closer look at unresolved questions in general critical care, acute respiratory distress syndrome, and more on Monday, May 19.
-
Third Clinical Year in Review Session Traces the Leading Edge in Bronchiectasis, Interstitial Lung Disease, Lung Transplant, and Pulmonary Infections
on
Read more: Third Clinical Year in Review Session Traces the Leading Edge in Bronchiectasis, Interstitial Lung Disease, Lung Transplant, and Pulmonary InfectionsDeep dives into the latest research and therapeutic advances in bronchiectasis, interstitial lung disease, lung transplant, and pulmonary infections were the focus of the third Clinical Year in Review series session on Tuesday, May 20, at ATS 2025 San Francisco.
-
Final Clinical Year in Review Session Highlights Advances in COPD, Pulmonary Vascular Disease, Pulmonary Rehabilitation, and Lung Cancer
on
Read more: Final Clinical Year in Review Session Highlights Advances in COPD, Pulmonary Vascular Disease, Pulmonary Rehabilitation, and Lung CancerThe Clinical Year in Review series at the ATS 2025 International Conference concluded on Wednesday, May 21, with a discussion of impactful studies spanning pulmonary vascular disease, COPD, pulmonary rehabilitation, and lung cancer.
ATS Conference News
San Francisco | May 16-21
We help the world breathe.